SAPPHIRE STUDYMED GLOBAL LTD

SAPPHIRE STUDYMED GLOBAL LTD
Statement of Financial Position
As at 28 February 2026

	2026
	£	£
Current assets	8
Creditors: amount falling due within one year	(3,217)
Net current assets		(3,209)
Total assets less current liabilities		(3,209)
Net assets		(3,209)


Capital and reserves		(3,209)

NOTES TO THE ACCOUNTS

General Information

SAPPHIRE STUDYMED GLOBAL LTD is a private company, limited by shares, registered in England and Wales, registration number 16223979, registration address 60 Milton Street, Walsall, WS1 4JT.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

Going concern basis

The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.	Average number of employees Average number of employees during the period was 1.

For the period ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the board of directors on 15 May 2026 and were signed on its behalf by:

--------------------------------
Moulali Rajasaheb HADIMANI
Director

Registered Number: 16223979
England and Wales
SAPPHIRE STUDYMED GLOBAL LTD

Unaudited Financial Statements

Period of accounts Start date: 03 February 2025 End date: 28 February 2026